title: Regulation of CREB activation by p38 mitogen activated protein kinase during human primary erythroblast differentiation.
abstract: Among the molecular events underlying erythroid differentiation, we analyzed the signalling pathway leading to cAMP response element binding (CREB) nuclear transcription factor activation. Normal donor blood light density cells differentiated to pro-erythroblasts during the proliferative phase (10 days) of the human erythroblast massive amplification (HEMA) culture, and to orthochromatic erythroblasts, during the differentiation phase (4 additional days) of the culture. Since erythropoietin was present all over the culture, also pro-erythroblasts left in proliferative medium for 14 days continued their maturation without reaching the final steps of differentiation. p38 mitogen activated protein kinase (p38 MAPK) and CREB maximal activation occurred upon 4 days of differentiation induction, whereas a lower activation was detectable in the cells maintained in parallel in proliferative medium (14 days). Interestingly, when SB203580, a specific p38 MAPK inhibitor, was added to the culture the percentage of differentiated cells decreased along with p38 MAPK and CREB phosphorylation. All in all, our results evidence a role for p38 MAPK in activating CREB metabolic pathway in the events leading to erythroid differentiation.
authors.affiliation: Dipartimento di Biomorfologia, Università G. d'Annunzio, Chieti-Pescara, Italy. v.digiacomo@unich.it
authors.forename: V
authors.initials: V
authors.lastname: Di Giacomo
authors.forename: S
authors.initials: S
authors.lastname: Sancilio
authors.forename: L
authors.initials: L
authors.lastname: Caravatta
authors.forename: R A
authors.initials: RA
authors.lastname: Rana
authors.forename: R
authors.initials: R
authors.lastname: Di Pietro
authors.forename: A
authors.initials: A
authors.lastname: Cataldi
mesh_terms: D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism*; D004900:Erythroblasts / Q000187:drug effects / Q000201:enzymology*; D004921:Erythropoietin / Q000378:metabolism; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D010766:Phosphorylation; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D015398:Signal Transduction; D013997:Time Factors; D048051:p38 Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: C115163:CREB1 protein, human; D017362:Cyclic AMP Response Element-Binding Protein; D007093:Imidazoles; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D004921:Erythropoietin; D048051:p38 Mitogen-Activated Protein Kinases; C093642:SB 203580